Assessment of Efficacy, Safety, and Quality of Life of 124 Patients Treated With Axitinib as Second-Line Therapy for Metastatic Renal-Cell Carcinoma: Experience in Real-World Clinical Practice in Japan

Autor:	Miyake, Hideaki, Harada, Ken-ichi, Ozono, Seiichiro, Fujisawa, Masato
Zdroj:	In Clinical Genitourinary Cancer February 2017 15(1):122-128
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect